N@N

AGO, MJN, NSR, NEPT, HGG, OMER Are Seasonally Ripe To Go Up In the Next Five Weeks

February 7, 2017 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net is monitoring the Seasonality of Assured Guaranty Ltd. (NYSE:AGO), Mead Johnson Nutrition Co (NYSE:MJN), NeuStar Inc. (NYSE:NSR), Neptun SA (NASDAQ:NEPT), hhgregg Inc. (NYSE:HGG), Omeros Corporation (NASDAQ:OMER) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. buyins.net is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

The following stocks are expected to go Up:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  AGO     Assured Guaranty Ltd.            3.25%            91.67% (11 of 12)    Monday, February 13th 2017
  MJN     Mead Johnson Nutrition Co        4.09%            100.00% (7 of 7)     Friday, February 17th 2017
  NSR     NeuStar Inc.                     2.44%            90.91% (10 of 11)    Wednesday, February 15th 2017
  NEPT    Neptun SA                        4.12%            100.00% (8 of 8)     Wednesday, February 15th 2017
  HGG     hhgregg Inc.                     8.65%            88.89% (8 of 9)      Tuesday, February 14th 2017
  OMER    Omeros Corporation               19.10%           85.71% (6 of 7)      Monday, March 6th 2017

Assured Guaranty Ltd. (NYSE:AGO) - Assured Guaranty Ltd., through its subsidiaries, provides credit protection products to public finance, infrastructure, and structured finance markets in the United States and internationally. It offers financial guaranty insurance that protects holders of debt instruments and other monetary obligations from defaults in scheduled payments. The company insures various debt obligations, including bonds issued by the United States state or municipal governmental authorities; and notes issued to finance infrastructure projects. It also insures and reinsures various types of the United States public finance obligations, such as general obligation, tax-backed, municipal utility, transportation, healthcare, higher education, housing revenue, infrastructure, investor-owned utility, and other public finance bonds; and various types of non-United States public finance obligations comprising infrastructure finance, regulated utilities, pooled infrastructure, and other public finance obligations. In addition, the company insures and reinsures various types of the United States and non-United States structured finance obligations, including pooled corporate obligations, residential mortgage-backed securities, financial products, consumer receivables securities, commercial mortgage-backed securities, commercial receivables securities, insurance securitization obligations, and other structured finance securities. Assured Guaranty Ltd. markets its financial guaranty insurance directly to issuers and underwriters of public finance and structured finance securities, as well as to investors in such obligations. The company was founded in 2003 and is based in Hamilton, Bermuda..

Mead Johnson Nutrition Co (NYSE:MJN) - Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children s nutrition, and other nutritional products. It offers routine infant formula products as a breast milk substitute for healthy infants for use as the infant s source of nutrition, as well as a supplement to breastfeeding under the Enfamil Premium, Enfapro Premium, Enfalac A+, and Enfamil A+ names; and solutions products to address common feeding tolerance problems, including spit-up, fussiness, gas, and lactose intolerance under the Enfamil Gentlease, Enfamil A.R., Enfamil ProSobee, and Enfamil LactoFree names. The company also provides specialty formula products, including formulas for addressing special medical needs, such as Nutramigen for cow s milk protein allergies, as well as Puramino, an amino acid formula for cow s milk protein allergies or multiple other food allergies; Enfamil Premature to meet the needs of premature and low birth weight infants; EnfaCare, a hypercaloric formula for premature babies at home; and produces medical foods for nutritional management of individuals with rare, inborn errors of metabolism comprising maple syrup urine disease and phenylketonuria. In addition, it offers children s nutrition products comprising products for meeting children s nutritional needs at toddlers and older children stage, as well as offer milk modifiers under the Enfagrow, Sustagen, Lactum, ChocoMilk, and Cal-C-Tose names; a range of other products, including pre-natal and post-natal nutritional supplements for expectant and nursing mothers under the Expecta and EnfaMama names; and pediatric vitamin products under the Enfamil Poly-Vi-Sol name, as well as multivitamins and iron supplements for infants. The company sells its products to mothers, health care professionals, and retailers in approximately 50 countries in Asia, North America, Latin America, and Europe. Mead Johnson Nutrition Company was founded in 1905 and is headquartered in Glenview, Illinois..

NeuStar Inc. (NYSE:NSR) - NeuStar, Inc. provides hard-to-replicate data sets and proprietary analytics worldwide. Its proprietary, cloud-based platforms and data sets offer informative, real-time analytics, which enable clients to make actionable, data-driven decisions. The company provides marketing services, including customer intelligence services that offer authoritative, cloud-based solutions to identify, verify, and segment existing and potential customers in real-time for marketing initiatives, and for fraud and risk mitigation; activation services, which enable online display ad targeting for prospect audiences and customers; and media intelligence platform that enables marketers to plan and allocate their marketing spend across sales channels and media platforms. It also offers security services, such as domain name systems solutions to protect client's Internet ecosystem and defend standard transmission control protocol based applications, including Websites, email servers, application programming interfaces, and databases; cloud-based distributed denial of service protection services that help its clients reduce risk, downtime, and revenue loss from cyber-attacks; and authoritative registries of Internet domain names for the .biz, .us, .co, .au, and .travel top-level domains, as well as international registry gateways and back-end support for generic top-level domains. In addition, it provides data services, such as carrier provisioning, caller authentication, common short codes, and user authentication and rights management; and number portability administration center services comprising dynamic routing of calls and text messages among communications service providers in the United States, and related connection services and system enhancements. The company serves clients in the communications, financial services, media and advertising, retail and e-commerce, Internet, and technology industries. NeuStar, Inc. was founded in 1996 and is headquartered in Sterling, Virginia..

Neptun SA (NASDAQ:NEPT) - Neptune Technologies & Bioressources Inc., a nutrition products company, develops nutrition solutions and specialty ingredients. The company develops solutions available in various delivery forms. It also offers specialty ingredients such as premium krill oil, marine oils, and seed oils. The company sells its premium krill oil under the OCEANO3 brand directly to consumers through oceano3.com in Canada and the United States, as well as in bulk to unbranded distributors. In addition, it also researches, develops, and commercializes new krill oil-based forms of omega-3 phospholipid therapies for treatment of severe hypertriglyceridemia. Neptune Technologies & Bioressources Inc. was founded in 1925 and is based in Laval, Canada..

hhgregg Inc. (NYSE:HGG) - hhgregg, Inc. operates as an appliance, consumer electronics, and furniture retailer. The company s appliances products include refrigerators, cooking ranges, dishwashers, freezers, washers and dryers, grills, air conditioners, and small home appliances; consumer electronics products comprise LED televisions, audio systems, cameras, and Blu-ray players; furniture, mattresses, and other home products; and computers, computer accessories, and tablets. As of July 7, 2016, it operated 226 brick-and-mortar stores in 20 states of the United States. The company was founded in 1955 and is headquartered in Indianapolis, Indiana..

Omeros Corporation (NASDAQ:OMER) - Omeros Corporation, a biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. It markets OMIDRIA for use during cataract surgery or intraocular lens replacement. The company s clinical products include OMS721 that is in Phase III clinical trials for the treatment of atypical hemolytic uremic syndrome; and in Phase II clinical trials for the treatment of thrombotic microangiopathies, IgA nephropathy, and other renal diseases. Its clinical programs also comprise OMS824, which is in Phase II clinical trials for the treatment of schizophrenia and Huntington's diseases; OMS405 that is in Phase II clinical trials for the treatment of opioid and nicotine addiction; and OMS201, which is in Phase I/II clinical trials for use during urological procedures. The company s preclinical programs include OMS527 for the treatment of addiction and compulsive disorders, as well as for movement disorders, such as Parkinson's disease; OMS616 to control surgical and traumatic bleeding; and OMS906 for the treatment of paroxysmal nocturnal hemoglobinuria and other alternative pathway disorders. Its preclinical programs also comprise GPR17 for the treatment of demyelinating disorders; GPR101 for appetite and eating disorders; GPR151 for the treatment of neuropathic pain and cognition; GPR161 for triple-negative breast cancer treatment; GPR174 for dysfunction of regulatory T-cell modulation; GPR183 for the treatment of osteoporosis and EBV-related diseases; and GPCR and Antibody Platform for CNS, metabolic, CV, oncologic, musculoskeletal, and other disorders. In addition, the company is developing OMS103 that has completed Phase III clinical trials for arthroscopic anterior cruciate ligament reconstruction and arthroscopic partial meniscectomy. Omeros Corporation was incorporated in 1994 and is based in Seattle, Washington..

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net